Ciprofioxacin decreases the rate of ethanol elimination in humans

Gut

Volumn 44, Issue 3, 1999, Pages 347-352

  Tillonen, J ^a   Homann, N ^a   Rautio, M ^b   Jousimies Somer, H ^b   Salaspuro, M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Acetaldehyde; Alcohol dehydrogenase; Ciprofloxacin; Colonic bacteria; Ethanol; Metabolism

Indexed keywords

ACETALDEHYDE; ALCOHOL; ALCOHOL DEHYDROGENASE; CATALASE; CIPROFLOXACIN; CYTOCHROME; ANTIINFECTIVE AGENT; CENTRAL DEPRESSANT AGENT;

ADULT; ALCOHOL METABOLISM; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FECES; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INTESTINE FLORA; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPECTROPHOTOMETRY; CASE CONTROL STUDY; DRUG EFFECT; ENTEROBACTERIACEAE; ENTEROCOCCUS; METABOLISM; OXIDATION REDUCTION REACTION;

ACETALDEHYDE; ADULT; ALCOHOL DEHYDROGENASE; ANTI-INFECTIVE AGENTS; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CIPROFLOXACIN; ENTEROBACTERIACEAE; ENTEROCOCCUS; ETHANOL; HUMANS; MALE; OXIDATION-REDUCTION;

EID: 0032586289     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.3.347     Document Type: Article

References (47)

1. Holford NHG. Clinical pharmacokinetics of ethanol. Clin Pharmacokinet 1987;13:273-92.
2. Lieber CS. Alcohol and the liver: 1991 update. Gastroenterology 1994;106:1085-105.
3. Ingelman-Sundberg M. Cytochrome P450 in alcohol metabolism. Alcohol Alcohol 1997;32:317.
4. Estonius M, Svensson S, Höög J-O. Alcohol dehydrogenase in human tissue: localisation of transcripts coding for five classes of the enzyme. FEBS Lett 1996;397:338-42.
5. Huang M-T, Huang C-C, Chen M-Y. In vivo uptake of ethanol and release of acetate in rat liver and GI. Life Sci 1993;53:165-70.
6. Utne HE, Winkler K. Hepatic and extrahepatic elimination of ethanol in cirrhosis. Scand J Gastroenterol 1980;15:297-304.
7. Halstedt CH, Robles EA, Mezey E. Distribution of ethanol in the human gastrointestinal tract. Am J Clin Nutr 1973;26:831-4.
8. Levitt MD, Doizaki W, Levine AS. Hypothesis: metabolic activity of the colonic bacteria influences organ injury from ethanol. Hepatology 1982;2:598-600.
9. Salaspuro M. Bacteriocolonic pathway for ethanol oxidation: characteristics and implications. Ann Med 1996; 28:195-200.
10. Cummings JH. Fermentation in the human large intestine: evidence and implications for health. Lancet 1983;i: 1206-8.
11. Neale AD, Scopes RK, Kelly JM, et al. The two alcohol dehydrogenases of Zymomonas mobilis. Purification by differential dye ligand chromatography, molecular characterisation and physiological roles. Eur J Biochem 1986;154: 119-24.
12. Poxton IR, Brown R, Sawyerr A, et al. Mucosa-associated bacterial flora of the human colon. J Med Microbiol 1997;46:85-91.
13. Stryer L. Glycolysis. In: Stryer L, ed. Biochemistry. 3rd edn. New York: WH Freeman, 1988:349-72.
14. MacFaddin JF. Catalase test. In: MacFaddin JF. Biochemical test for identification of medical bacteria. Baltimore: Williams & Wilkins, 1976:29-35.
15. Davis R, Markham A, Balfour JA. Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability. Drugs 1996;51:1019-74.
16. Shah PM, Enzensberger R, Glogau O, et al. Influence of oral ciprofloxacin or ofloxacin on the fecal flora of healthy volunteers. Am J Med 1987;82(suppl 4A):333-5.
17. Rohwedder RW, Bergan T, Thorsteinsson SB, et al. Transintestinal elimination of ciprofloxacin. Diagn Microbiol Infect Dis 1990;13:127-33.
18. Brismar B, Edlund C, Malmborg A-S, et al. Ciprofloxacin concentrations and impact of the colon microflora in patients undergoing colorectal surgery. Antimicrob Agents Chemother 1990;34:481-3.
19. Jokelainen K, Nosova T, Koivisto T, et al. Inhibition of bacteriocolonic pathway for ethanol oxidation by ciprofloxacin in rats. Life Sci 1997;61:1755-62.
20. Summanen P, Baron EJ, Citron DM, et al. Wadsworth anaerobic bacteriology manual. 5th edn. Belmont, California: Star Publishing, 1993.
21. Murray PR, Baron EJ, Pfaller MA, et al, eds. Manual of clinical microbiology. 6th edn. Washington DC: ASM Press, 1995.
22. Jokelainen K, Roine RP, Väänänen H, et al. In vitro acetaldehyde formation by human colonic bacteria. Gut 1994;35:1271-4.
23. Stowell AR, Greenway RM, Batt RD. Acetaldehyde formation during deproteinization of human blood samples containing ethanol. Biochem Med 1977;18:392-401.
24. Lowry OH, Rosenbrough NJ, Farr AL, et al. Protein measurement with folin phenol reagent. J Biol Chem 1951; 193:265-75.
25. Aebi H. Catalase. In: Bergmeyer HU, ed. Methods in enzymatic analysis. 3rd edn. Weinheim, FRG: Verlag Chemie, 1983:673-84.
26. Fraser AG. Pharmacokinetic interactions between alcohol and other drugs. Clin Pharmacokinet 1997;33:79-90.
27. Dan M, Verbin N, Gorea A, et al. Concentration of ciprofloxacin in human liver, gallbladder, and bile after oral administration. Eur J Clin Pharmacol 1987;32:217-18.
28. Radant JM, Marchbanks CR, Dudley MN. Interactions of fluoroquinolones with other drugs: mechanism, variability, clinical significance, and management. Clin Infect Dis 1992; 14:272-84.
29. Mizuki Y, Fujiwara I, Yamaguchi T. Pharmacokinetic interactions related to the chemical structures of fluoroquinolones. J Antimicrob Chemother 1996;37(suppl A):41-55.
30. McLellan RA, Drobitch RK, Monshouwer M, et al. Fluroquoinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human. Drug Metab Dispos 1996;24:1134-8.
31. Asai H, Imaoka S, Kuroki T, et al. Microsomal ethanol oxidizing system activity by human hepatic cytochrome P450s. J Pharmacol Exp Ther 1996;277:1004-9.
32. Nix DE, DeVito JM, Whitbread MA, et al. Effect of multiple dose oral ciprofloxacin on the pharmacokinetics of theophylline and indocyanine green. J Antimicrob Chemother 1987;19:263-9.
33. Jokelainen K, Siitonen A, Jousimies-Somer H, et al. In vitro alcohol dehydrogenase-mediated acetaldehyde production by aerobic bacteria representing the normal colonic flora in man. Alcohol Clin Exp Res 1996;20:967-72.
34. Baraona E, Julkunen RJK, Tannebaum L, et al. Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats. Gastroenterology 1986;90:103-10.
35. Jokelainen K, Matysiak-Budnik T, Mäkisalo H, et al. High intracolonic acetaldehyde levels produced by a bacteriocolonic pathway for ethanol oxidation in piglets. Gut 1996;39:100-4.
36. Salaspuro M. Microbial metabolism of ethanol and acetaldehyde and clinical consequences. Addict Biol 1997; 2:35-40.
37. Nosova T, Jokelainen K, Jousimies-Somer H, et al. Ethanol and acetaldehyde metabolism by Lactobacillus and Bifido-bacterium strains representing normal human anaerobic colonic flora. Alcohol Alcohol 1996;31:323.
38. Kamali F, No influence of ciprofloxacin on ethanol disposition. A pharmacokinetic-pharmacodynamic interaction study. Eur J Clin Pharmacol 1994;47:71-4.
39. Yin S-J, Liao C-S, Lee Y-C, et al. Genetic polymorphism and activities of human colon alcohol and aldehyde dehydrogenases: no gender and age differences. Alcohol Clin Exp Res 1994;18:1256-60.
40. Koivisto T, Salaspuro M. Aldehyde dehydrogenases of the rat colon: comparison with other tissues of the alimentary tract and the liver. Alcohol Clin Exp Res 1996;20:551-5.
41. Nosova T, Jokelainen K, Kaihovaara P, et al. Aldehyde dehydrogenase activity and acetate production by aerobic bacteria representing the normal flora of human large intestine. Alcohol Alcohol 1996;31:555-64.
42. Matysiak-Budnik T, Jokelainen K, Kärkkäinen P, et al. Hepatotoxicity and absorption of extrahepatic acetaldehyde in rats. J Pathol 1996;178:469-74.
43. Bjarnason I, Ward K, Peters TJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet 1984;i: 179-82.
44. Bode JC, Bode C, Heidelbach R, et al. Jejunal microflora in patients with chronic alcohol abuse. Hepatogastroenterology 1984;31:30-4.
45. Fukui H, Brauner B, Bode JC, et al. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 1991;12:162-9.
46. Nanji AA, Khettry U, Sadrzadeh SMH, et al. Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am J Pathol 1993;142:367-73.
47. Adachi Y, Moore LE, Bradford BU, et al. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995;108:218-24.